NovaSeq 6000 Sequencing System is designed to adapt to your needs so groundbreaking discoveries are always within reach. It's flexible, scalable science on your terms. NovaSeq 6000 offers deeper ...
Propel your research forward to impact the world, not the environment. The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions ...
Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...
Hosted on MSN1mon
Illumina targets high single-digit revenue growth by 2027 amid NovaSeq X transitionHe noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...
The firm is not resting on its laurels, either; with the new NovaSeq X Series (launched in 2023), Illumina can now enable a roughly $200 genome including bioinformatics onboard the system ...
The firm is not resting on its laurels, either; with the new NovaSeq X Series (launched in 2023), Illumina can now enable a roughly $200 genome including bioinformatics onboard the system ...
These solutions leverage the power of Illumina's leading NovaSeq X series platform and will enable researchers to derive breakthrough insights around the drivers of disease. The company will also ...
Hosted on MSN1mon
Earnings call transcript: Illumina Q4 2024 beats EPS, stock fallsThe company launched several new products, including the NovaSeq X series. Illumina is focusing on expansion in multiomics and data services. Illumina's performance in Q4 2024 showed modest growth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results